Finance

Beta
Lists
OKYO:NASDAQ
OKYO Pharma Ltd
$1.66
-2.35%
(-0.040) 1D
Jun 3, 10:04:06 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OKYO...
Open
$1.74
High
$1.74
Low
$1.66
Mkt. cap
90.00M
Avg. vol.
51.86K
Volume
7.25K
52-wk high
$3.35
52-wk low
$1.44
EPS
-$0.15
Beta
-0.08
Shares outstanding
51.37M
No. of employees
4
Open
$1.74
High
$1.74
Low
$1.66
Mkt. cap
90.00M
Avg. vol.
51.86K
Volume
7.25K
52-wk high
$3.35
52-wk low
$1.44
EPS
-$0.15
Beta
-0.08
Shares outstanding
51.37M
No. of employees
4
News stories
From sources across the web
About OKYO Pharma Ltd
CEO-
Employees4
Founded2007
Headquarters-
SectorBiotechnology
Websiteokyopharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Revenue
-
-
-
-
Cost of goods sold
1.86M
1.86M
1.27M
1.27M
Cost of revenue
1.86M
1.86M
1.27M
1.27M
Research and development expenses
19.18K
19.18K
-22.02K
-22.02K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
19.18K
19.18K
-22.02K
-22.02K
Total operating expenses
1.88M
1.88M
1.25M
1.25M
Operating income
-1.88M
-1.88M
-1.25M
-1.25M
Other non operating income
-6.68K
-6.68K
-
-
EBT including unusual items
-1.94M
-1.94M
-1.29M
-1.29M
EBT excluding unusual items
-1.94M
-1.94M
-1.29M
-1.29M
Income tax expense
-922.97K
-922.97K
26.00
26.00
Effective tax rate
47.67%
47.67%
-
-
Other operating expenses
-
-
-
-
Net income
-1.01M
-1.01M
-1.29M
-1.29M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
2.74K
2.74K
-
-
Interest expense
-55.95K
-55.95K
-42.29K
-42.29K
Net interest expenses
-53.21K
-53.21K
-42.29K
-42.29K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.88M
-1.88M
-1.25M
-1.25M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer